| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $141.1M | +2.7% |
| Cost of Revenue | $89.0M | -1.1% |
| Gross Profit | $52.1M | +9.9% |
| R&D Expense | $13.9M | +34.7% |
| SG&A Expense | $25.7M | +6.1% |
| Operating Income | $12.6M | -2.7% |
| Pre-tax Income | $20.9M | +18.9% |
| Income Tax | $2.2M | +99.9% |
| Net Income | $15.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.9M | -4.9% |
| Short-term Investments | $9.3M | +72.3% |
| Accounts Receivable | $29.3M | -16.0% |
| Inventory | $89.6M | +36.0% |
| Current Assets | $183.5M | +14.6% |
| Total Assets | $370.1M | +11.3% |
| Current Liabilities | $75.3M | +57.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.8M | -165.2% |
| Capital Expenditures | $28.5M | -4.0% |
| Investing Cash Flow | -$25.2M | +35.0% |
| Financing Cash Flow | $38.0M | +564.3% |
| Free Cash Flow | -$37.2M | -13.0% |
| +8.5% |
| EPS (Basic) | $0.37 | +5.7% |
| EPS (Diluted) | $0.37 | +8.8% |
| Total Liabilities |
| $80.3M |
| +53.9% |
| Stockholders' Equity | $221.6M | +4.8% |